Skip to content
Screener

Bio-Techne Corp. TECH Q3 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$311.4MMiss by $4.7M
EPS$0.53Miss by $0.02
Revenue estimate$316.1M
EPS estimate$0.55

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$292.4M
EPS estimate$0.46

Financials

Q3 2026

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$8.18B-11.8%
Enterprise value$8.26B-13.6%
P/S6.8×-0.9×

Profitability

See full
Gross margin65%-0.8pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Segments

By product

See full
Consumables$257.3M-0.2%
Instruments$27.7M+5.9%
Service$21.4M-21.3%
Royalty$5.0M-1.4%

By segment

See full
Protein Sciences$226.2M-0.7%
Diagnostics And Spatial Biology$85.6M-4.1%

FAQ

When did Bio-Techne Corp. report Q3 2026 earnings?
Bio-Techne Corp. (TECH) reported Q3 2026 earnings on May 6, 2026 before market open.
What were Bio-Techne Corp.'s Q3 2026 revenue and EPS?
Bio-Techne Corp. reported revenue of $311.4M and eps of $0.53 for Q3 2026.
Did Bio-Techne Corp. beat estimates in Q3 2026?
Revenue missed the consensus estimate of $316.1M by $4.7M. EPS missed the consensus estimate of $0.55 by $0.02.
How did Bio-Techne Corp.'s Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.5% from $316.2M a year earlier and eps declined 5.4% from $0.56.
Where can I find Bio-Techne Corp.'s Q3 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-055887) and the 10-Q periodic report (0001104659-26-056302) directly on SEC EDGAR. The filing index links above go to sec.gov.